Biovitrum to Present at the 25th Annual JPMorgan Healthcare Conference.STOCKHOLM, Sweden -- Biovitrum's (STO:BVT BVT Bouvet Island (ISO Country code) BVT Brevet BVT Bournville Village Trust (UK) BVT Build Verification Test (Software testing process) ) CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Mats Pettersson will give a corporate presentation at the 25th Annual JPMorgan Healthcare Conference being held January 8-11, 2007, at the Westin St.Francis in San Francisco, USA. The presentation is scheduled to take place on Monday January 8 at 11.00 AM (PST PST Paroxysmal supraventricular tachycardia, see there ). A live and archived webcast will be available at https://events.jpmorgan.com. The presentation material will be available on www.biovitrum.com under the link presentations on the investor relations page. About Biovitrum Biovitrum is one of the largest biopharma companies in Europe. With operations in Sweden and in the UK Biovitrum conducts research and develops pharmaceuticals for unmet medical needs both for common diseases and conditions that affect smaller patient populations. Biovitrum has a broad and balanced R&D portfolio with several projects in clinical and preclinical phases for the treatment of obesity, diabetes, inflammation and eye and blood diseases as well as a number of well defined niche indications. Biovitrum develops and produces protein-based drugs on a contractual basis and markets a range of specialist pharmaceuticals primarily in the Nordic countries. Biovitrum has revenues of approximately SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 1.2 billion and 550 employees. Biovitrum is listed on the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries. since September 15, 2006. For more information see www.biovitrum.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion